Skip to main content
Erschienen in: Wiener Medizinische Wochenschrift 3-4/2016

01.03.2016 | themenschwerpunkt

Sexualität bei Übergewicht und Adipositas

verfasst von: Prim. Dr. Heidemarie Abrahamian, Univ. Prof. Dr. Alexandra Kautzky-Willer

Erschienen in: Wiener Medizinische Wochenschrift | Ausgabe 3-4/2016

Einloggen, um Zugang zu erhalten

Zusammenfassung

Die Assoziation zwischen Adipositas und Sexualfunktionsstörungen ist in vielen Studien beschrieben. Neurobiologische, hormonelle und vaskuläre Störungen sowie psychische Erkrankungen gelten bei beiden Geschlechtern als Hauptursachen. Sexuelles Interesse und Verlangen, sexuelle Erregung, Orgasmus, schmerzhafter Geschlechtsverkehr und Ejakulation können betroffen sein. Die Datenlage zu Prävalenzzahlen für Sexualfunktionsstörungen bei adipösen Menschen ist aufgrund der Studien mit kleinen Fallzahlen beschränkt. Für das Screening von Sexualfunktionsstörungen stehen zwei validierte Scores zur Verfügung. Der Internationale Index of Erectile Function-5 (IIEF5), der 15 Fragen enthält und der Female Sexual Function Index (FSFI), der 19 Fragen enthält sind multidimensionale und validierte diagnostische Methoden für das jeweilige Geschlecht. Die Behandlung umfasst Lebensstilveränderungen mit vermehrter körperlicher Aktivität, Gewichtskontrolle, gesunde Ernährung und Beendigung von Tabakkonsum. Testosteron Substitution in Fällen eines nachgewiesenen Hypogonadismus und Therapie mit PDE-5 Inhibitoren sind gut dokumentierte Behandlungsoptionen bei Männern. Therapieoptionen für Frauen sind nicht so gut evaluiert, wobei Fibanserin, Testosteron, Bupropion und Oxytocin wirksam sein dürften.
Literatur
1.
Zurück zum Zitat Kolotkin RL, Zunker C, Ostbye T. Sexual functioning and obesity: a review. Obesity (Silver Spring). 2012;20(12):2325–33.CrossRef Kolotkin RL, Zunker C, Ostbye T. Sexual functioning and obesity: a review. Obesity (Silver Spring). 2012;20(12):2325–33.CrossRef
2.
Zurück zum Zitat Lewis RW, Fugl-Meyer KS, Corona G, et al. Definitions/epidemiology/risk factors for sexual dysfunction. J Sex Med. 2010;7:1598–607.CrossRefPubMed Lewis RW, Fugl-Meyer KS, Corona G, et al. Definitions/epidemiology/risk factors for sexual dysfunction. J Sex Med. 2010;7:1598–607.CrossRefPubMed
3.
Zurück zum Zitat Laumann EO, Glasser DB, Neves RC, Moreira ED, GSSAB Investigators Group. A population-based survey of sexual activity, sexual problems and associated help-seeking behaviour patterns in mature adults in the United States of America. Int J Impot Res. 2009;21(3):171–8.CrossRefPubMed Laumann EO, Glasser DB, Neves RC, Moreira ED, GSSAB Investigators Group. A population-based survey of sexual activity, sexual problems and associated help-seeking behaviour patterns in mature adults in the United States of America. Int J Impot Res. 2009;21(3):171–8.CrossRefPubMed
4.
Zurück zum Zitat Bond DS, Wing RR, Sivamainthan V, et al. Significant resolution of female sexual dysfunction after bariatric surgery. Surg Obes Realt Dis. 2011;7(1):1–7.CrossRef Bond DS, Wing RR, Sivamainthan V, et al. Significant resolution of female sexual dysfunction after bariatric surgery. Surg Obes Realt Dis. 2011;7(1):1–7.CrossRef
5.
Zurück zum Zitat Bajos N, Wellings K, Laborde C, Moreau C, CSF Group. Sexuality and obesity, a gender perspective: results from French national random probability survey of sexual behaviours. BMJ 2010;340:c2573.CrossRefPubMedPubMedCentral Bajos N, Wellings K, Laborde C, Moreau C, CSF Group. Sexuality and obesity, a gender perspective: results from French national random probability survey of sexual behaviours. BMJ 2010;340:c2573.CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Dhinsda S, Miller MG, Whirter CL, et al. Testosterone concentrations in diabetic and non diabetic obese men. Diabetes Care. 2010;33:1186–92.CrossRef Dhinsda S, Miller MG, Whirter CL, et al. Testosterone concentrations in diabetic and non diabetic obese men. Diabetes Care. 2010;33:1186–92.CrossRef
7.
Zurück zum Zitat Han TS, Tajar A, O’Neill TW, et al. Impaired quality of life and sexual function in overweight and obese men: the European Male Ageing Study. Eur J Endocrinol. 2011;164:1003–11.CrossRefPubMed Han TS, Tajar A, O’Neill TW, et al. Impaired quality of life and sexual function in overweight and obese men: the European Male Ageing Study. Eur J Endocrinol. 2011;164:1003–11.CrossRefPubMed
8.
Zurück zum Zitat Bhasin Sh, Enzlin P, Covielleo A, Basson R. Sexual dysfunction in men and women with endocrine disorders. Lancet. 2007;369:597–609.CrossRefPubMed Bhasin Sh, Enzlin P, Covielleo A, Basson R. Sexual dysfunction in men and women with endocrine disorders. Lancet. 2007;369:597–609.CrossRefPubMed
9.
Zurück zum Zitat Kinzl JF, Trefalt E, Fiala M, Hotter A, Biebl W, Aigner F. Partnership, sexuality, and sexual disorders in morbidly obese women: consequences of weight loss after gastric banding. Obesity Surg. 2001;11(4):455–8.CrossRef Kinzl JF, Trefalt E, Fiala M, Hotter A, Biebl W, Aigner F. Partnership, sexuality, and sexual disorders in morbidly obese women: consequences of weight loss after gastric banding. Obesity Surg. 2001;11(4):455–8.CrossRef
10.
Zurück zum Zitat Puhl RM, Brownell KD. Confronting and Coping with weight stigma: an investigation of overweight and obese adults. Obesity (Silver Spring). 2006;14(10):1802–15.CrossRef Puhl RM, Brownell KD. Confronting and Coping with weight stigma: an investigation of overweight and obese adults. Obesity (Silver Spring). 2006;14(10):1802–15.CrossRef
11.
Zurück zum Zitat Esposito K, Giugliano F, Ciotola M, De Sio M, DÀrmiento M, Giugliano D. Obesity and sexual dysfunction, male and female. Int J Impot Res. 2008;20:358–65.CrossRefPubMed Esposito K, Giugliano F, Ciotola M, De Sio M, DÀrmiento M, Giugliano D. Obesity and sexual dysfunction, male and female. Int J Impot Res. 2008;20:358–65.CrossRefPubMed
12.
Zurück zum Zitat Pastuszak AW, Badhiwala N, Lipshultz LI, Khera M. Depression is correlated with the psychological and physical aspects of sexual dysfunction in men. Int J Impot Res. 2013;25:194–9.CrossRefPubMed Pastuszak AW, Badhiwala N, Lipshultz LI, Khera M. Depression is correlated with the psychological and physical aspects of sexual dysfunction in men. Int J Impot Res. 2013;25:194–9.CrossRefPubMed
13.
Zurück zum Zitat Harte CB, Meston CM. Association between smoking cessation and sexual health in men. BJU. 2012;109(6):888–96.CrossRef Harte CB, Meston CM. Association between smoking cessation and sexual health in men. BJU. 2012;109(6):888–96.CrossRef
14.
Zurück zum Zitat Cheng JYW, NG EML, Chen RYL. Physical activity and erectile dysfunction: meta-analysis of population –based studies. Int J Impot Res. 2007;19:245–52.CrossRefPubMed Cheng JYW, NG EML, Chen RYL. Physical activity and erectile dysfunction: meta-analysis of population –based studies. Int J Impot Res. 2007;19:245–52.CrossRefPubMed
16.
Zurück zum Zitat Rosen R, Riley A, Wagner G, et al. The International Index of Erectile Function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology. 1997;49:822–30.CrossRefPubMed Rosen R, Riley A, Wagner G, et al. The International Index of Erectile Function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology. 1997;49:822–30.CrossRefPubMed
17.
Zurück zum Zitat Wiegel M, Meston C, Rosen R. The female sexual function index (FSFI): cross-validation and development of clinical cutoff scores. J Sex Marital Ther. 2005;31(1):1–20.CrossRefPubMed Wiegel M, Meston C, Rosen R. The female sexual function index (FSFI): cross-validation and development of clinical cutoff scores. J Sex Marital Ther. 2005;31(1):1–20.CrossRefPubMed
18.
Zurück zum Zitat Dandona P, Dhinsda S. Update: hypogonadotropic hypogonadism in type 2 diabetes and obesity. J Clin Endocrinol Metab. 2011;96:2634–51. Dandona P, Dhinsda S. Update: hypogonadotropic hypogonadism in type 2 diabetes and obesity. J Clin Endocrinol Metab. 2011;96:2634–51.
19.
20.
Zurück zum Zitat Mogri M, Dhinsda S, Quattrin T, Ghanim H, Dandona P. Testosterone concentrations in young pubertal and post-pubertal obese males. Clin Endocrinol (Oxf). 2012;78:593–9.CrossRef Mogri M, Dhinsda S, Quattrin T, Ghanim H, Dandona P. Testosterone concentrations in young pubertal and post-pubertal obese males. Clin Endocrinol (Oxf). 2012;78:593–9.CrossRef
21.
Zurück zum Zitat Giagulli VA, Kaufmann JM, Vermeulen A. Pathogenesis of the decreased androgen levels in obese men. J Clin Endocrinol Metab. 1994;79:997–100.PubMed Giagulli VA, Kaufmann JM, Vermeulen A. Pathogenesis of the decreased androgen levels in obese men. J Clin Endocrinol Metab. 1994;79:997–100.PubMed
22.
Zurück zum Zitat Vermeulen A, Goemaere S, Kaufmann JM. Testosterone body composition and aging. J Endocrinol Invest. 1999;22 Suppl 5:110–6.PubMed Vermeulen A, Goemaere S, Kaufmann JM. Testosterone body composition and aging. J Endocrinol Invest. 1999;22 Suppl 5:110–6.PubMed
23.
Zurück zum Zitat Esposito K, Ciotola M, Giugliano F, et al. Association of body weight with sexual function in woman. Int J Impot Res. 2007;19:353–7.CrossRefPubMed Esposito K, Ciotola M, Giugliano F, et al. Association of body weight with sexual function in woman. Int J Impot Res. 2007;19:353–7.CrossRefPubMed
24.
Zurück zum Zitat Morotti E, Battaglia B, Paradisi R, et al. Body mass index, stunkard figure rating scale, and sexuality in young italian women: a pilot study. J Sex Med. 2013;10(4):1034–43.CrossRefPubMed Morotti E, Battaglia B, Paradisi R, et al. Body mass index, stunkard figure rating scale, and sexuality in young italian women: a pilot study. J Sex Med. 2013;10(4):1034–43.CrossRefPubMed
25.
26.
Zurück zum Zitat Corona G, Ricca V, Bandini E, et al. Selective serotonin reuptake inhibitor-induced sexual dysfunction. J Sex Med. 2009;6(5):1259–69.CrossRefPubMed Corona G, Ricca V, Bandini E, et al. Selective serotonin reuptake inhibitor-induced sexual dysfunction. J Sex Med. 2009;6(5):1259–69.CrossRefPubMed
27.
Zurück zum Zitat Bond DS, Vithiananthan S, Leahey TM, et al. Prevalence and degree of sexual dysfunction in a sample of women seeking bariatric surgery. Surg Obes Relat Dis. 2009;5(6):698–704.CrossRefPubMedPubMedCentral Bond DS, Vithiananthan S, Leahey TM, et al. Prevalence and degree of sexual dysfunction in a sample of women seeking bariatric surgery. Surg Obes Relat Dis. 2009;5(6):698–704.CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat Nicolai MPJ, Liem SS, Both S, et al. A review of the positive and negative effects of cardiovascular drugs on sexual function: a proposed table for use in clinical practice. Neth Heart J. 2014;22:11–9.CrossRefPubMedPubMedCentral Nicolai MPJ, Liem SS, Both S, et al. A review of the positive and negative effects of cardiovascular drugs on sexual function: a proposed table for use in clinical practice. Neth Heart J. 2014;22:11–9.CrossRefPubMedPubMedCentral
29.
Zurück zum Zitat Hartmann U. Depression and sexual dysfunction: aspects of a multi-faceted relationship. Psychiatr Prax. 2007;34 Suppl 3:314–17.CrossRef Hartmann U. Depression and sexual dysfunction: aspects of a multi-faceted relationship. Psychiatr Prax. 2007;34 Suppl 3:314–17.CrossRef
30.
Zurück zum Zitat Schreiner-Engel P, Schiavi RC. Lifetime psychopathology in individuals with low sexual desire. J Nerv Ment Dis. 1986;174:646–51.CrossRefPubMed Schreiner-Engel P, Schiavi RC. Lifetime psychopathology in individuals with low sexual desire. J Nerv Ment Dis. 1986;174:646–51.CrossRefPubMed
31.
Zurück zum Zitat Gregorian RS, Golden KA, Bahce A, Goodman C, Kwong WJ, Khan ZM. Antidepressant-induced sexual dysfunction. Annal Pharmacother. 2002;36:1577–89.CrossRef Gregorian RS, Golden KA, Bahce A, Goodman C, Kwong WJ, Khan ZM. Antidepressant-induced sexual dysfunction. Annal Pharmacother. 2002;36:1577–89.CrossRef
32.
Zurück zum Zitat Zajecka J. Strategies for the treatment of antidepressant-induced sexual dysfunction. J Clin Psychiatry. 2001;23:1040–58. Zajecka J. Strategies for the treatment of antidepressant-induced sexual dysfunction. J Clin Psychiatry. 2001;23:1040–58.
33.
Zurück zum Zitat Kinzl JF, Schrattenecker M, Traweger C, Aigner F, Fiala M, Biebl W. Quality of life in morbidly obese patients after surgical weight loss. Obes Surg. 2007;17(2):229–35.CrossRefPubMed Kinzl JF, Schrattenecker M, Traweger C, Aigner F, Fiala M, Biebl W. Quality of life in morbidly obese patients after surgical weight loss. Obes Surg. 2007;17(2):229–35.CrossRefPubMed
34.
Zurück zum Zitat Kinzl JF, Trefalt E, Fiala M, Hotter A, Biebl W, Aigner F. Partnership, sexuality, and sexual disorders in morbidly obese women: consequences of weight loss after gastric banding. Obes Surg 2001;11(4):455–8.CrossRefPubMed Kinzl JF, Trefalt E, Fiala M, Hotter A, Biebl W, Aigner F. Partnership, sexuality, and sexual disorders in morbidly obese women: consequences of weight loss after gastric banding. Obes Surg 2001;11(4):455–8.CrossRefPubMed
35.
Zurück zum Zitat Heidler S, Temml C, Broessner C, et al. Is the metabolic syndrome an independent risk factor for erectile dysfunction? J Urol. 2007;177(2):651–4.CrossRefPubMed Heidler S, Temml C, Broessner C, et al. Is the metabolic syndrome an independent risk factor for erectile dysfunction? J Urol. 2007;177(2):651–4.CrossRefPubMed
36.
Zurück zum Zitat Ponholzer A, Temml C, Mock K, Marszalek M, Obermayr R, Madersbacher S. Prevalence and risk factors for erectile dysfunction in 2869 men using a validated questionnaire. Eur Urol. 2005;47:80–6.CrossRefPubMed Ponholzer A, Temml C, Mock K, Marszalek M, Obermayr R, Madersbacher S. Prevalence and risk factors for erectile dysfunction in 2869 men using a validated questionnaire. Eur Urol. 2005;47:80–6.CrossRefPubMed
37.
Zurück zum Zitat Ponholzer A, Roehlich M, Racz U, Temml C, Madersbacher S. Female sexual dysfunction in a healthy Austrian vohort: prevalence and risk factors. Eur Urol. 2005;47(3):366–74.CrossRefPubMed Ponholzer A, Roehlich M, Racz U, Temml C, Madersbacher S. Female sexual dysfunction in a healthy Austrian vohort: prevalence and risk factors. Eur Urol. 2005;47(3):366–74.CrossRefPubMed
38.
Zurück zum Zitat Esposito K, Giugliano F, Di Palo C, et al. Effect of lifestyle changes on erectile dysfunction in obese men. JAMA. 2004;291:2978–84.CrossRefPubMed Esposito K, Giugliano F, Di Palo C, et al. Effect of lifestyle changes on erectile dysfunction in obese men. JAMA. 2004;291:2978–84.CrossRefPubMed
39.
Zurück zum Zitat Hammoud A, Gibson M, Hunt SC, et al. Effect of Roux-en-Y gastric bypass surgery on the sex steroids and quality of life in obese men. J Clin Endocrinol Metab. 2009;94(4):1329–32.CrossRefPubMedPubMedCentral Hammoud A, Gibson M, Hunt SC, et al. Effect of Roux-en-Y gastric bypass surgery on the sex steroids and quality of life in obese men. J Clin Endocrinol Metab. 2009;94(4):1329–32.CrossRefPubMedPubMedCentral
40.
Zurück zum Zitat Basson R, Brotto LA. Sexual psychophysiology and effects of sildenafil citrate in oestrogenised women with acquired genital arousal disorder and impaired orgasm: a randomised controlled trial. BJOG. 2003;110:1014–24.CrossRefPubMed Basson R, Brotto LA. Sexual psychophysiology and effects of sildenafil citrate in oestrogenised women with acquired genital arousal disorder and impaired orgasm: a randomised controlled trial. BJOG. 2003;110:1014–24.CrossRefPubMed
41.
Zurück zum Zitat Basson R, McInnes R, Smith MD, Hodgson G, Koppiker N. Efficacy and safety of sildenafil citrate in women with sexual dysfunction associated with female sexual arousal. J Womens Health Gend Based Med. 2002;11:367–77.CrossRefPubMed Basson R, McInnes R, Smith MD, Hodgson G, Koppiker N. Efficacy and safety of sildenafil citrate in women with sexual dysfunction associated with female sexual arousal. J Womens Health Gend Based Med. 2002;11:367–77.CrossRefPubMed
42.
Zurück zum Zitat Simon JA, Kingsberg SA, Shumel B, et al. Efficacy and safety of fibanserin in postmeopausal women with hypoactive sexual desire disorder: results of the SNOWDROP trial. Menopause. 2014;21:633.CrossRefPubMed Simon JA, Kingsberg SA, Shumel B, et al. Efficacy and safety of fibanserin in postmeopausal women with hypoactive sexual desire disorder: results of the SNOWDROP trial. Menopause. 2014;21:633.CrossRefPubMed
43.
Zurück zum Zitat Safarinejad MR, Hosseini SY, Asgari MA, et al. A randomized, double-blind, placebo-controlled study of the efficacy and safety of bupropion for treating hypoactive sexual desire disorder in ovulating women. BJU Int. 2010;106:832.CrossRefPubMed Safarinejad MR, Hosseini SY, Asgari MA, et al. A randomized, double-blind, placebo-controlled study of the efficacy and safety of bupropion for treating hypoactive sexual desire disorder in ovulating women. BJU Int. 2010;106:832.CrossRefPubMed
44.
Zurück zum Zitat Muin DA, Woltz M, Marculescu R, et al. Effect of long-term intranasal oxytocin on sexual dysfunction in premenopausal and postmenopausal women: a randomized trial. Fertil Steril. 2015;104(3):715–23.CrossRefPubMed Muin DA, Woltz M, Marculescu R, et al. Effect of long-term intranasal oxytocin on sexual dysfunction in premenopausal and postmenopausal women: a randomized trial. Fertil Steril. 2015;104(3):715–23.CrossRefPubMed
45.
Zurück zum Zitat Günzler C, Berner MM. Efficacy of psychosocial interventions in men and women with sexual dysfunctions – a systematic review of controlled clinical trials: part2 – the efficacy of psychosocial interventions for female sexual dysfunction. J Sex Med. 2012;9(12):3108–25.CrossRefPubMed Günzler C, Berner MM. Efficacy of psychosocial interventions in men and women with sexual dysfunctions – a systematic review of controlled clinical trials: part2 – the efficacy of psychosocial interventions for female sexual dysfunction. J Sex Med. 2012;9(12):3108–25.CrossRefPubMed
46.
Zurück zum Zitat Berner M, Günzler C. Efficacy of psychosocial interventions in men and women with sexual dysfunctions – a systematic review of controlled clinical trials: part1 – the efficacy of psychosocial interventions for male sexual dysfunction. J Sex Med. 2012;9(12):3089–107.CrossRefPubMed Berner M, Günzler C. Efficacy of psychosocial interventions in men and women with sexual dysfunctions – a systematic review of controlled clinical trials: part1 – the efficacy of psychosocial interventions for male sexual dysfunction. J Sex Med. 2012;9(12):3089–107.CrossRefPubMed
47.
Zurück zum Zitat Nehra A, Jackson G, Miner M, et al. The Princeton III consensus recommendations for the management of erectile dysfunction and cardiovascular disease. Mayo Clin Proc. 2012;87(8):766–78.CrossRefPubMedPubMedCentral Nehra A, Jackson G, Miner M, et al. The Princeton III consensus recommendations for the management of erectile dysfunction and cardiovascular disease. Mayo Clin Proc. 2012;87(8):766–78.CrossRefPubMedPubMedCentral
Metadaten
Titel
Sexualität bei Übergewicht und Adipositas
verfasst von
Prim. Dr. Heidemarie Abrahamian
Univ. Prof. Dr. Alexandra Kautzky-Willer
Publikationsdatum
01.03.2016
Verlag
Springer Vienna
Erschienen in
Wiener Medizinische Wochenschrift / Ausgabe 3-4/2016
Print ISSN: 0043-5341
Elektronische ISSN: 1563-258X
DOI
https://doi.org/10.1007/s10354-016-0430-9

Weitere Artikel der Ausgabe 3-4/2016

Wiener Medizinische Wochenschrift 3-4/2016 Zur Ausgabe

themenschwerpunkt

Adipositas im Alter